Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

09.10.2017

9 AIDS Res Hum Retroviruses
3 HIV Med
1 Int J Cancer
3 J Clin Oncol
1 J Immunol
11 J Infect Dis
2 J Med Virol
2 J Virol
1 JAMA
2 Lancet
2 Lancet Glob Health
5 Lancet HIV
1 MMWR Morb Mortal Wkly Rep
1 Nat Med
1 PLoS Comput Biol
15 PLoS One
1 Science
1 Vaccine
1 Virology
1 Virology (Auckl)



    AIDS Res Hum Retroviruses

  1. CASSEB J, Fonseca LAM, Duarte A
    Is it possible to control HIV infection in a middle-income country through a multidisciplinary approach?
    AIDS Res Hum Retroviruses. 2017 Oct 2. doi: 10.1089/AID.2017.0106.
    >> Share

  2. ROBERSON JL, Lagasca AM, Kan VL
    Comparison of the Hepatitis C Continua of Care between HCV/HIV Co-Infected and HCV Mono-Infected Patients in Two Treatment Eras during 2008-2015.
    AIDS Res Hum Retroviruses. 2017 Oct 3. doi: 10.1089/AID.2017.0092.
    >> Share

  3. DEZZUTTI CS, Park SY, Marks K, Lawlor S, et al
    Heterogeneity of HIV-1 replication in ectocervical and vaginal tissue ex vivo.
    AIDS Res Hum Retroviruses. 2017 Oct 6. doi: 10.1089/AID.2017.0107.
    >> Share

  4. KARLSSON I, Borggren M, Jensen SS, Heyndrickx L, et al
    Immunization with clinical HIV-1 Env proteins induces broad antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies in a rabbit vaccination model.
    AIDS Res Hum Retroviruses. 2017 Oct 6. doi: 10.1089/AID.2017.0140.
    >> Share

  5. MATSUDA EM, Coelho LP, Romero G, Moraes MJ, et al
    High prevalence of drug resistance mutations among patients failing first-line antiretroviral therapy and predictors of virological response 24 weeks after switch to second-line therapy in Sao Paulo State, Brazil.
    AIDS Res Hum Retroviruses. 2017 Oct 2. doi: 10.1089/AID.2017.0052.
    >> Share

  6. ZANOLINI A, Chipungu J, Vinikoor M, Bosomprah S, et al
    HIV self-testing in Lusaka Province, Zambia: acceptability, comprehension of testing instructions, and individual preferences for self-test kit distribution in a population-based sample of adolescents and adults.
    AIDS Res Hum Retroviruses. 2017 Oct 2. doi: 10.1089/AID.2017.0156.
    >> Share

  7. VIEGAS EO, Tembe N, Nilsson C, Meggi B, et al
    Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.
    AIDS Res Hum Retroviruses. 2017 Oct 2. doi: 10.1089/AID.2017.0121.
    >> Share

  8. ALEMNJI GA, Chase M, Branch S, Guevara G, et al
    Improving Laboratory Efficiency in the Caribbean to Attain the World Health Organization HIV Treat All Recommendations.
    AIDS Res Hum Retroviruses. 2017 Oct 1. doi: 10.1089/AID.2017.0158.
    >> Share

  9. HILEMAN CO, McComsey GA
    The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV-Infection.
    AIDS Res Hum Retroviruses. 2017 Oct 3. doi: 10.1089/AID.2017.0164.
    >> Share


    HIV Med

  10. COZZI-LEPRI A, Zangerle R, Machala L, Zilmer K, et al
    Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12557.
    >> Share

  11. FUREGATO M, Mitchell H, Ogaz D, Woodhall S, et al
    The role of frequent HIV testing in diagnosing HIV in men who have sex with men.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12558.
    >> Share

  12. TRON L, Lert F, Spire B, Dray-Spira R, et al
    Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    HIV Med. 2017;18:181-195.
    >> Share


    Int J Cancer

  13. TANAKA LF, Latorre MDRDO, Gutierrez EB, Curado MP, et al
    Cancer survival in people with aids: A population-based study from Sao Paulo, Brazil.
    Int J Cancer. 2017 Oct 3. doi: 10.1002/ijc.31081.
    >> Share


    J Clin Oncol

  14. LIN NU, Prowell T, Tan AR, Kozak M, et al
    Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.
    J Clin Oncol. 2017 Oct 2:JCO2017740761. doi: 10.1200/JCO.2017.74.0761.
    >> Share

  15. KIM ES, Bruinooge SS, Roberts S, Ison G, et al
    Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
    J Clin Oncol. 2017 Oct 2:JCO2017737916. doi: 10.1200/JCO.2017.73.7916.
    >> Share

  16. ULDRICK TS, Ison G, Rudek MA, Noy A, et al
    Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.
    J Clin Oncol. 2017 Oct 2:JCO2017737338. doi: 10.1200/JCO.2017.73.7338.
    >> Share


    J Immunol

  17. ABANA CO, Pilkinton MA, Gaudieri S, Chopra A, et al
    Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects.
    J Immunol. 2017 Oct 2. pii: ji1700851. doi: 10.4049/jimmunol.1700851.
    >> Share


    J Infect Dis

  18. BOEIJEN LL, Montanari NR, de Groen RA, van Oord GW, et al
    Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    >> Share

  19. NOGUERA-JULIAN M, Edgil D, Harrigan PR, Sandstrom P, et al
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    >> Share

  20. WEITZMANN MN, Vikulina T, Roser-Page S, Yamaguchi M, et al
    Homeostatic Expansion of CD4+ T-cells Promotes Cortical and Trabecular Bone Loss while CD8+ T-cells Induce Trabecular Bone Loss Only.
    J Infect Dis. 2017 Aug 25. doi: 10.1093.
    >> Share

  21. GODFREY C, Bobkova M, Boucher C, Ravasi G, et al
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    >> Share

  22. NING T, Wolfe A, Nie J, Huang W, et al
    Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  23. CHIKATA T, Murakoshi H, Koyanagi M, Honda K, et al
    Control of HIV-1 by an HLA-B*52:01-C*12:02 protective haplotype.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    >> Share

  24. AKE JA, Schuetz A, Pegu P, Wieczorek L, et al
    Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  25. MCLAREN PJ, Pulit SL, Gurdasani D, Bartha I, et al
    Evaluating the impact of functional genetic variation on HIV-1 control.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    >> Share

  26. LIU Y, Gaisa MM, Wang X, Swartz TH, et al
    Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  27. ASMUTH DM, Thompson CG, Chun TW, Ma ZM, et al
    Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal GALT Immune Reconstitution in HIV-infected Patients Initiating Antiretroviral Therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    >> Share

  28. GODFREY C, Thigpen MC, Crawford KW, Jean-Phillippe P, et al
    Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    >> Share


    J Med Virol

  29. LIU Z, Fang Q, Zuo J, Chen Y, et al
    Global Epidemiology of Human Herpesvirus 8 in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    J Med Virol. 2017 Oct 3. doi: 10.1002/jmv.24960.
    >> Share

  30. AMPONSAH-DACOSTA E, Selabe SG, Mphahlele MJ
    Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    J Med Virol. 2017 Oct 2. doi: 10.1002/jmv.24956.
    >> Share


    J Virol

  31. BRACQ L, Xie M, Lambele M, Vu LT, et al
    T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading.
    J Virol. 2017 Oct 4. pii: JVI.01237-17. doi: 10.1128/JVI.01237.
    >> Share

  32. GIFT SK, Leaman DP, Zhang L, Kim AS, et al
    Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.
    J Virol. 2017 Oct 4. pii: JVI.01216-17. doi: 10.1128/JVI.01216.
    >> Share


    JAMA

  33. ANDREWS B, Semler MW, Muchemwa L, Kelly P, et al
    Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.
    JAMA. 2017;318:1233-1240.
    >> Share


    Lancet

  34. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    >> Share

  35. KAZATCHKINE MD
    Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.
    Lancet. 2017;390:1611-1612.
    >> Share


    Lancet Glob Health

  36. THOMAS R, Burger R, Harper A, Kanema S, et al
    Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Lancet Glob Health. 2017 Sep 27. pii: S2214-109X(17)30367.
    >> Share

  37. DONALD KA
    Health-related quality of life of people with HIV in Zambia and South Africa.
    Lancet Glob Health. 2017 Sep 27. pii: S2214-109X(17)30384.
    >> Share


    Lancet HIV


  38. Correction.
    Lancet HIV. 2017 Sep 27. pii: S2352-3018(17)30177.
    >> Share

  39. PHANUPHAK P, Phanuphak N
    Socioeconomic empowerment in an acute HIV cohort.
    Lancet HIV. 2017 Sep 29. pii: S2352-3018(17)30150.
    >> Share

  40. DONG KL, Moodley A, Kwon DS, Ghebremichael MS, et al
    Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study.
    Lancet HIV. 2017 Sep 29. pii: S2352-3018(17)30146.
    >> Share

  41. TAVOSCHI L, Gomes Dias J, Pharris A
    New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data.
    Lancet HIV. 2017 Sep 26. pii: S2352-3018(17)30155.
    >> Share

  42. SEELEY J
    HIV diagnosis increasing in older adults in Europe.
    Lancet HIV. 2017 Sep 26. pii: S2352-3018(17)30151.
    >> Share


    MMWR Morb Mortal Wkly Rep

  43. TANNER MR, Bush T, Nesheim SR, Weidle PJ, et al
    Retention in Medical Care Among Insured Children with Diagnosed HIV Infection - United States, 2010-2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:1033-1038.
    >> Share


    Nat Med

  44. ESTES JD, Kityo C, Ssali F, Swainson L, et al
    Defining total-body AIDS-virus burden with implications for curative strategies.
    Nat Med. 2017 Oct 2. doi: 10.1038/nm.4411.
    >> Share


    PLoS Comput Biol

  45. PULLER V, Neher R, Albert J
    Estimating time of HIV-1 infection from next-generation sequence diversity.
    PLoS Comput Biol. 2017;13:e1005775.
    >> Share


    PLoS One

  46. BILINSKI A, Birru E, Peckarsky M, Herce M, et al
    Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: A retrospective cohort study.
    PLoS One. 2017;12:e0185699.
    >> Share

  47. BROTHERS TD, Kirkland S, Theou O, Zona S, et al
    Predictors of transitions in frailty severity and mortality among people aging with HIV.
    PLoS One. 2017;12:e0185352.
    >> Share

  48. COETZEE J, Jewkes R, Gray GE
    Cross-sectional study of female sex workers in Soweto, South Africa: Factors associated with HIV infection.
    PLoS One. 2017;12:e0184775.
    >> Share

  49. INGHELS M, Niangoran S, Minga A, Yoboue JM, et al
    Missed opportunities for HIV testing among newly diagnosed HIV-infected adults in Abidjan, Cote d'Ivoire.
    PLoS One. 2017;12:e0185117.
    >> Share

  50. MULDOON KM, Armstrong-Heimsoth A, Thomas J
    Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States.
    PLoS One. 2017;12:e0185635.
    >> Share

  51. WEISS B, Pollack AA
    Barriers to global health development: An international quantitative survey.
    PLoS One. 2017;12:e0184846.
    >> Share

  52. SANCHEZ-DEL COJO M, Lopez-Huertas MR, Diez-Fuertes F, Rodriguez-Mora S, et al
    Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.
    PLoS One. 2017;12:e0185677.
    >> Share

  53. STUART RM, Kerr CC, Haghparast-Bidgoli H, Estill J, et al
    Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics.
    PLoS One. 2017;12:e0185077.
    >> Share

  54. TRAVASSOS AG, Netto E, Xavier-Souza E, Nobrega I, et al
    Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women.
    PLoS One. 2017;12:e0185423.
    >> Share

  55. LI H, Nykoluk M, Li L, Liu LR, et al
    Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0186079.
    >> Share

  56. GRABAR S, Selinger-Leneman H, Abgrall S, Pialoux G, et al
    Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.
    PLoS One. 2017;12:e0184441.
    >> Share

  57. GOVENDER K, Cowden RG, Oppong Asante K, George G, et al
    Validation of the child and youth resilience measure among South African adolescents.
    PLoS One. 2017;12:e0185815.
    >> Share

  58. ODOYO-JUNE E, Agot K, Grund JM, Onchiri F, et al
    Predictors of voluntary medical male circumcision prevalence among men aged 25-39 years in Nyanza region, Kenya: Results from the baseline survey of the TASCO study.
    PLoS One. 2017;12:e0185872.
    >> Share

  59. SMITH JM, Moss JA, Srinivasan P, Butkyavichene I, et al
    Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
    PLoS One. 2017;12:e0185946.
    >> Share

  60. CASTEL AD, Terzian A, Hart R, Rayeed N, et al
    Use of national standards to monitor HIV care and treatment in a high prevalence city-Washington, DC.
    PLoS One. 2017;12:e0186036.
    >> Share


    Science

  61. COHEN MS, Corey L
    Broadly neutralizing antibodies to prevent HIV-1.
    Science. 2017;358:46-47.
    >> Share


    Vaccine

  62. NONZEE NJ, Baldwin SB, Cui Y, Singhal R, et al
    Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31134.
    >> Share


    Virology

  63. NAHABEDIAN J, Sharma A, Kaczmarek ME, Wilkerson GK, et al
    Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.
    Virology. 2017;512:180-186.
    >> Share


    Virology (Auckl)

  64. ESAU D
    Viral Causes of Lymphoma: The History of Epstein-Barr Virus and Human T-Lymphotropic Virus 1.
    Virology (Auckl). 2017;8:1178122X17731772.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016